Femtech Fund Launched to Support Women’s Health Innovation in Île-de-France

0 comments

Île-de-France Region Launches €50 Million Femtech Fund to Accelerate Women’s Health Innovation

The Île-de-France Region has launched a dedicated investment fund, Femtech Île-de-France, to support startups developing medical and technological solutions for women’s health. The fund aims to reach €50 million, with the Region contributing €5 million, and will be deployed by Turenne Groupe, with scientific support from Université Paris Cité.

Addressing a Critical Gap in Healthcare Funding

Femtech Île-de-France will focus on filling a critical funding gap for early-stage companies – those between the ideation phase and their first significant fundraising rounds (Series A). This period often presents the greatest challenges for securing financing.

Investment Focus: A Holistic Approach to Women’s Health

The fund will invest in companies developing innovative technologies and projects addressing the specific needs of women’s health across all stages of life. This includes:

  • Biotechnology
  • Medical devices
  • Digital solutions with high medical value
  • Solutions for improving well-being
  • Treatments for limiting symptoms associated with various pathologies

The Rise of Femtech and its Socio-Economic Impact

The emergence of “Femtech” – a strategic sector with high potential – is transforming healthcare pathways and improving the quality of life for women. This innovation is expected to have significant positive socio-economic consequences. Femtech is currently a rapidly growing ecosystem.

Partnerships Driving Innovation

Turenne Groupe’s Health Innovation team will manage the fund’s deployment, leveraging their expertise in the small cap market. Université Paris Cité will provide interdisciplinary scientific expertise in women’s health, ensuring the fund supports projects with a strong scientific foundation.

Regional Commitment to Women’s Health

The launch of Femtech Île-de-France, initially announced in June 2025 at VivaTech, marks a first in France and Europe, reflecting the Île-de-France Region’s commitment to innovation and addressing health inequalities. Women, on average, spend 25% of their lives in poorer health than men, highlighting the necessitate for targeted investment in their healthcare.

Source, Source, Source

Related Posts

Leave a Comment